Chad Brodt is a Cardiology physician affiliated with Stanford University. OpenAlex indexes 52 publications with 392 citations (h-index 10); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1950 University Ave
East Palo Alto, CA 943032250
Telephone
650-617-8100Provider last certified this registry record 30 Dec 2019.
Clinical trials
- Low Fluoroscopy Afib Ablation Registry
Sponsor: Stanford University
- Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF)
Sponsor: Biosense Webster, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AtriCure, Inc.Program year202537 payments$28,508openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year202520 payments
- Biosense Webster, Inc.Program year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.7%Beta blocker28.2%Carvedilol34%Metoprolol Succinate28%Sotalol14%Sotalol Af14%Atenolol5%Metoprolol Tartrate5%Part D<11 patientsStatin10.5%Atorvastatin Calcium44%Rosuvastatin Calcium44%Pravastatin Sodium12%Part D<11 patients+ 10 more classes in this area
Blood & clotting
19.9%Factor Xa inhibitor19.9%Eliquis78%Xarelto22%Part D≥57 patientsMetabolism & gastrointestinal
5.4%SGLT2 inhibitor3%Jardiance100%Part D<11 patientsPotassium supplement2.3%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-A-16860-ACC PREDICTION OF INCIDENT DEMENTIA IN ATRIAL FIBRILLATION PATIENTS
Journal of the American College of Cardiology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Renumathy Dhanasekaran, MD, PhD
Stanford University
Euan Ashley, MD
Stanford University
Sarah Donaldson, MD
Stanford University
Peter Fitzgerald, MD
Stanford University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”